English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Impulsivity and Saliva Cortisol in Patients with Suicide Attempt and Controls

MPS-Authors
/persons/resource/persons80279

Bronisch,  Thomas
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Lewitzka, U., Bauer, M., Ripke, B., Bronisch, T., & Günther, L. (2017). Impulsivity and Saliva Cortisol in Patients with Suicide Attempt and Controls. NEUROPSYCHOBIOLOGY, 75(4), 162-168. doi:10.1159/000484664.


Cite as: https://hdl.handle.net/21.11116/0000-0001-9608-D
Abstract
Objectives: The objective of this study was to prove concepts in the characterization of suicidal patients and the possible usefulness of those markers to potentially identify patients with a higher risk for suicidality. Methods: Patients with a recent suicide attempt were compared with patients suffering from depression, adjustment disorder, anxiety, or eating disorders without suicidality, healthy controls and remitted patients with a history of at least 1 suicide attempt (>= 1 year). We analyzed impulsivity (Barratt Impulsivity Scale, BIS) and saliva cortisol concentrations. Results: Independently of suicidality and disease state patients display higher BIS scores than healthy controls. Saliva cortisol levels tend to be higher in patients in the acute disease state than in remitted patients and healthy controls. Conclusions: Saliva cortisol may be a useful marker that reveals alterations in nonsuicidal patients suffering from depression, adjustment disorder, anxiety, or eating disorders who might be at risk. (C) 2018 S. Karger AG, Basel